PATH’s Vaccine Cost Calculators: Resources to inform immunisation decision-making

LOOK AT THIS IF YOU'RE INTERESTED IN:

Examining estimated vaccination program costs for different vaccine products.

HOW YOU CAN USE THIS MATERIAL:

Decision-makers and implementers in middle-income countries can use these vaccine cost calculators to compare vaccination program costs and cold chain volumes associated with different product options for pneumococcal and rotavirus vaccines, enabling evidence-based decision-making to support the introduction and continued use of these important vaccines.

OVERVIEW:

PATH’s Vaccine Cost Calculators provide an easy way to compare the costs of certain vaccination programs with each vaccine product available in the global market. These Excel-based tools are available in multiple languages, and we have two different sets of calculators: one for middle-income countries and another for countries eligible for co-funding from Gavi, the Vaccine Alliance. Both sets of calculators allow country-level policymakers to input local data and then compare estimated vaccination program costs for different vaccine products and presentations, exploring multiple vaccine options at once.

For middle-income countries, PATH currently offer calculators for pneumococcal conjugate vaccines and rotavirus vaccines. Both calculators enable users to compare the estimated cold chain volume and financial costs of different vaccination programs annually and for a total period of five years. Users also can add domestically produced vaccine options that are not available in the global market, as well as compare costs for up to three different scenarios of multi-vaccine use for countries that plan to use more than one product at the same time.

For Gavi-eligible countries, PATH currently offer calculators for pneumococcal conjugate vaccines, rotavirus vaccines, and human papillomavirus vaccines. The pneumococcal and rotavirus vaccine calculators allow users to compare the estimated cold chain volume and financial costs of different vaccination programs annually and for a total period of five years. The human papillomavirus vaccine calculator provides comparisons of vaccination program costs annually and for a period of 10 years.

You May Also Like

Linked Brief: New vaccine introduction in middle income countries: HPV demand generation and vaccine acceptance strategies – Key takeaways from Linked’s workshop held on October 22-23rd, 2024

The Linked Immunisation Action Network welcomed immunisation practitioners from six middle-income countries (MICs) along with global and regional technical experts, for a workshop focused on “New Vaccines Introduction in Middle Income Countries: HPV demand generation and vaccine acceptance strategies”. Held in Istanbul, Turkey, on 22-23 October 2024, the objective of this workshop was to facilitate … Read More

Download
File size: 319.55K

Linked Workshop: New vaccine introduction in Middle Income Countries: HPV Demand generation and vaccine acceptance strategies

Linked convened country representatives and partners from Cuba, Kosovo, Mongolia, Philippines, Tunisia, and Viet Nam, to discuss challenges to build trust, acceptance, and uptake of the HPV vaccine, as well as tools and strategies to support countries to overcome these challenges. Explore country experiences in the workshop materials below. Country Posters Cuba Kosovo Mongolia Philippines … Read More

Linked Webinar: One-dose HPV vaccination: Evidence, lessons learned and implementation strategies, with experiences from Guyana and Estonia

Choosing or switching to a single dose HPV vaccination can simplify delivery and lower program costs. It can also help reduce the potential for supply shortages and loss to follow-up. Linked held a virtual learning session to aid countries who are in the initial stages of introducing the HPV vaccine or considering a switch, strengthening … Read More